Debt to Equity Ratio: A measure of a company's financial leverage calculated by dividing its long-term debt by shareholders equity. Calculated as: Total Debt / Shareholders Equity
Appili Therapeutics Inc. (APLIF) had Debt to Equity Ratio of -0.84 for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
-- |
|
$-0.90M |
|
-- |
|
-- |
|
$1.16M |
|
$-1.16M |
|
$0.28M |
|
$-0.88M |
|
$-0.88M |
|
$-0.90M |
|
$-0.90M |
|
$-0.90M |
|
$-0.90M |
|
$-1.16M |
|
$-1.16M |
|
121.27M |
|
121.27M |
|
$-0.01 |
|
$-0.01 |
|
| Balance Sheet Financials | |
$1.36M |
|
$0.01M |
|
$0.01M |
|
$1.37M |
|
$11.44M |
|
$0.51M |
|
$0.51M |
|
$11.95M |
|
$-10.58M |
|
$-10.58M |
|
$-10.58M |
|
121.27M |
|
| Cash Flow Statement Financials | |
$-0.00M |
|
-- |
|
$-0.03M |
|
$0.89M |
|
$0.81M |
|
$-0.07M |
|
$0.01M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.12 |
|
-- |
|
-- |
|
-0.05 |
|
|
Debt to Equity Ratio |
-0.84 |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-0.00M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
8.54% |
|
8.54% |
|
-65.76% |
|
8.97% |
|
$-0.09 |
|
$0.00 |
|
$0.00 |
|